超声造影在经腹与经直肠超声用于宫颈癌分期中的可靠性研究
这项回顾性研究纳入39例经全子宫切除术证实为IB和II期宫颈癌的患者,比较经腹与经直肠常规超声及超声造影(CEUS)评估肿瘤大小和分期与术后病理的一致性。结果显示CEUS提高了经腹超声评估肿瘤直径的可靠性(ICC从0.672升至0.735),经直肠超声联合CEUS分期与病理一致性最高(κ=0.785),与MRI相近(κ=0.789)。
要点
- 经直肠超声联合CEUS分期与术后病理一致性最高(κ=0.785),与MRI(κ=0.789)相近。
- CEUS提高经腹超声评估肿瘤直径的可靠性,ICC从0.672升至0.735。
- 不均匀增强和灌注缺损在>2 cm宫颈癌中更常见(分别为50%,20/40和52.5%,21/40)。
核心结论
- 对于IB和IIA期宫颈癌,CEUS可辅助经腹和经直肠超声评估国际妇产科联盟分期;经直肠超声联合CEUS分期与病理一致性良好,与MRI相当。
研究设计与样本
- 回顾性研究,2020年10月至2023年3月连续纳入39例经全子宫切除术证实的IB和II期宫颈癌住院患者,获取经腹和经直肠常规超声及CEUS图像以及MRI,评估肿瘤大小和分期并与病理标本分析一致性。
关键影像表现/征象
- CEUS可反映肿瘤异质性。
- 不均匀增强在>2 cm宫颈癌中占50%(20/40)。
- 灌注缺损在>2 cm宫颈癌中占52.5%(21/40)。
- 灌注缺损在中至低分化肿瘤中更常见,占66.67%(20/30)。
诊断标准与关键数值
- 经腹超声评估肿瘤直径的ICC为0.672,加用CEUS后为0.735。
- 经直肠超声评估肿瘤直径的ICC为0.780,加用CEUS后为0.796。
- 经腹超声分期加权κ值为0.689,加用CEUS后为0.731。
- 经直肠超声分期κ值为0.758,加用CEUS后为0.785。
- 经直肠超声联合CEUS分期κ值为0.785,MRI分期κ值为0.789。
临床应用与阅片要点
- 对IB和IIA期宫颈癌,可联合经腹超声和经直肠超声加CEUS评估国际妇产科联盟分期。
- 经直肠超声联合CEUS分期与病理一致性良好,与MRI相当。
- CEUS显示的不均匀增强和灌注缺损可提示肿瘤异质性,在>2 cm肿瘤中更常见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This retrospective study aimed to evaluate the consistency of transrectal contrast-enhanced ultrasonography (TR-CEUS) with post-operative pathology and the value of contrast-enhanced ultrasonography (CEUS) in staging surgically treated cervical cancer when combined with conventional ultrasonography (US).
METHODS: From October 2020 to March 2023, hospitalized patients with stage IB and II cervical cancer confirmed by total hysterectomy were consecutively enrolled. The standard images of US and CEUS by transabdominal (TA-US/CEUS) and transrectal (TR-US/CEUS) approaches and magnetic resonance imaging (MRI) were acquired, on which the size and stage of the tumors were evaluated, and the consistency of results with the pathological specimen was analyzed.
RESULTS: Thirty-nine patients with cervical cancer were finally enrolled in this study. The results showed that CEUS significantly improved the reliability of TA-US in evaluating tumor diameter; the intraclass correlation coefficient (ICC) was from 0.672 to 0.735. TR-US indicated good reliability with or without the addition of CEUS (ICC = 0.796 and 0.780). In terms of tumor staging, CEUS improved the consistency of transabdominal (weighted κ values from 0.689 to 0.731) and transrectal staging of tumors (κ from 0.758 to 0.785), and the staging of TR-US combined with TR-CEUS had the highest consistency with post-operative results, similar to MRI (κ, respectively 0.785 and 0.789). CEUS can reflect the heterogeneity of the tumor. Heterogeneous enhancement and perfusion defects were more common in >2 cm cervical cancer (50%, 20/40 and 52.5%, 21/40), respectively, and perfusion defects were more common in moderately to poorly differentiated tumors (66.67%, 20/30).
CONCLUSION: For stage IB and IIA cervical cancer, CEUS can aid in assessing the International Federation for Gynecology and Obstetrics staging of tumors alongside TA-US and TR-US. The combination of TR-US and TR-CEUS has shown good consistency with pathology in the staging of cervical cancer, comparable to that of MRI.
引用
- Zhang J, Xiang JD, Jia C, et al. Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in Staging Cervical Cancer: A Reliability Study. Ultrasound Med Biol. 2023. PMID: 37495499. doi:10.1016/j.ultrasmedbio.2023.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。